Welcome to your clients’ section

Discover the latest news and navigate with the submenu.

Capture d’écran 2016-03-14 à 15.32.21

OUR NEXT EVENTS

Washington – April 1-5, 2017

Lyon – April 20-22, 2017

London – May 8-10, 2017

Bordeaux – May 11-12, 2017

San Diego – June 19-22, 2017

Boston – July 18-20, 2017

  • LILLE, 6TH SEPTEMBER 2016

    OCR, the company revolutionising the selection of effective drug candidates for cancer, raises €1.25m from Newfund, NFA and the management team in order to accelerate its growth.

  • LILLE, 16TH JULY 2015

    OCR and Pierre Fabre’s Phase I Clinical Pharmacology Study published in prestigious Clinical Cancer Research journal.

  • LILLE, O2ND APRIL 2015

    OCR and Ecrins Therapeutics initiate €1.9m “Dog to Man” pioneering translational research programme to advance human and vet oncology treatment.

  • LILLE, 23RD MARCH 2015

    OCR and PRISM announce ground-breaking research collaboration to advance real-time diagnosis using mass spectrometry.

  • LILLE, 30TH JANUARY 2015

    OCR strengthens veterinary and R&D expertise to respond to the needs of the pharmaceutical industry.

LOG OUT